Results 21 to 30 of about 7,754 (200)

Development of a transcutaneous form of desloratadine

open access: yesResearch Results in Pharmacology
Introduction: For people with allergies, it is not always possible to prevent allergens admission to the body. For this reason, it is essential to create a long-acting drug that can prevent an allergic reaction. The very promising option is a transdermal
Valentin P. Ageev   +10 more
doaj   +2 more sources

A COMPARISON OF TWO DESLORATADINE PREPARATIONS’ (SOLUTION AND SYRUP) EFFECTIVENESS AND TOLERABILITY IN ATOPIC DERMATITIS TREATMENT IN CHILDREN OF EARLY AGE

open access: yesВопросы современной педиатрии, 2015
Objective: The aim of our study was to compare the effectiveness and tolerability of desloratadine solution vs syrup formulation in children with atopic dermatitis.
I. V. Makarova   +4 more
doaj   +2 more sources

Versatile Detection of Cellular Protein via Fluorescence Anisotropy. [PDF]

open access: yesAdv Sci (Weinh)
Cell Lysate Fluorescence Anisotropy (CFAST) utilizes long lifetime dye‐labeled nanobodies for rapid protein quantification in minimally purified, complex cell lysate. When coupled with cellular thermal shift, CFAST allows high‐throughput detection of endogenous protein‐small molecule engagement, facilitating the discovery of novel binders for ...
Tang Q   +12 more
europepmc   +2 more sources

Successful Rapid Desensitization to Ceftazidime/Avibactam in a Patient With Cystic Fibrosis and Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Pneumonia: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Ceftazidime/avibactam (CAZ‐AVI) is an important therapeutic option for multidrug‐resistant (MDR) Pseudomonas aeruginosa infections; however, hypersensitivity reactions may preclude its use and create significant therapeutic challenges. We report a 21‐year‐old woman with cystic fibrosis and recurrent MDR P.
Zhou Z   +6 more
europepmc   +2 more sources

Desloratadine in the treatment of allergic rhinitis [PDF]

open access: yes, 2022
Alergiczny nieżyt nosa, czyli stan zapalny błony śluzowej nosa, charakteryzujący się wyciekaniem wydzieliny z nosa i jej ściekaniem po tylnej ścianie gardła oraz innymi objawami (zatkanie nosa utrudniające oddychanie i powodujące problemy ze snem ...
Łuszczyna, Wojciech   +2 more
core   +1 more source

DEVELOPMENT OF METHODS FOR IDENTIFICATION OF DESLORATADINE IN MEDICINES [PDF]

open access: yes, 2015
SUMMARY. Methods of identification of desloratadine in medicines by absorpt i on spectrophotometry and TLC have beendeveloped.KEY WORDS: desloratadine, identification, spectrophotometery, thin layer chromatography ...
Logoyda, Liliya
core   +1 more source

Comparison of the effect of desloratadine and montelukast combined treatment with desloratadine monotherapy on clinical symptoms and quality of life of patients with persistent allergic rhinitis [PDF]

open access: yesمجله علوم پزشکی فیض (پیوسته), 2023
Background and Aim: Allergic rhinitis is the most common atopic disorder and a chronic inflammatory disease of the airways, which can lead to disruption and decrease the patient's quality of life in the long term.
Meghdad Rahati   +3 more
doaj  

Study of embryotoxic effects of intranasally administred desloratadine on laboratory animals. [PDF]

open access: yesMedičnì Perspektivi, 2017
The study was conducted to detect possible changes in embryogenesis and negative effects of third generation antihistamine – desloratadine – after intranasal administration of 1.3 mg/m3 and 13.0 mg/m3 of the substance to laboratory animals during their ...
Т. А. Alekhina   +2 more
doaj   +2 more sources

Efficiency and safety of desloratadine in combination with compound glycyrrhizin in the treatment of chronic urticaria: a meta-analysis and systematic review of randomised controlled trials

open access: yesPharmaceutical Biology, 2021
Context Desloratadine, an H1 receptor antagonist, is suggested as an effective first-line drug for chronic urticarial (CU). However, the efficacy of desloratadine alone is limited, and the recurrence rate of CU is relatively high.
Yulong Wen   +3 more
doaj   +1 more source

Uremic pruritus in hemodialysis patients: treatment with desloratidine versus gabapentin

open access: yesBrazilian Journal of Nephrology, 2012
INTRODUCTION: Uremic pruritus is common among dialysis patients. Effective treatments are not readily available. Early evidence with antihistamines and gabapentin indicate variable effects.
Diego Marquez   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy